Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term story

Amgen stock holds steady as biotech pipeline and U.S. market presence underpin long-term story  ad-hoc-news.de

Summary aggregated from ad-hoc-news.de's public RSS feed. The full reporting belongs to ad-hoc-news.de — please read it on their site.